Experiences with Next-Generation Sequencing in Relapsed Acute Myeloid Leukemia: A Patient Case Series

Схожие документы

• Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use
  по: Bacher, Ulrike, et al.
  Опубликовано: (2018)
• Pitfalls in the molecular follow up of NPM1 mutant acute myeloid leukemia
  по: Bacher, Ulrike, et al.
  Опубликовано: (2018)
• sBCMA Plasma Level Dynamics and Anti-BCMA CAR-T-Cell Treatment in Relapsed Multiple Myeloma
  по: Katja Seipel, et al.
  Опубликовано: (2022-03-01)
• Hematopoietic Stem Cell Mobilization With Plerixafor Is Safe and Effective in Poorly Mobilizing Acute Myeloid Leukemia Patients
  по: Shumilov, Evgenyi, et al.
  Опубликовано: (2019)
• Molecular minimal residual disease negativity and decreased stem cell mobilization potential predict excellent outcome after autologous transplant in NPM1 mutant acute myeloid leukemia
  по: de Benito, Alvaro de Santiago, et al.
  Опубликовано: (2020)